Annora Pharma Partners with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

▴ (Left to Right) Mr. Siddharth Reddy, Managing Director of AltiusHub, and Mr. Bhaskar Reddy, Director at Hetero Group, following the announcement of the strategic partnership between AltiusHub and Annora Pharma.
Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian pharmaceutical manufacturer, has expanded its collaboration with AltiusHub.

National, India, May 28, 2026: Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian pharmaceutical manufacturer, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace, and regulatory compliance platform across its export operations.

The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply chain. The rollout supports compliance across key export markets, including the US, EU, GCC, LATAM, and ASEAN regions.

Annora Pharma aims to achieve real-time visibility across 100% of serialized drug products within three months. This visibility will span the full journey from packaging line to export dispatch.

The unified platform replaces fragmented legacy systems. It supports serialization, aggregation, and multi-market regulatory reporting. It also integrates with Annora Pharma’s Level 3 packaging infrastructure.

AltiusHub’s AI-driven analytics and automated exception management help improve operational efficiency. They also accelerate issue resolution and strengthen compliance oversight across markets.

The rollout reflects a broader shift in the pharmaceutical industry. Manufacturers are moving away from fragmented and vendor-dependent serialization systems. They are now adopting unified platforms that offer better control, faster implementation, and stronger supply chain visibility.

The deployment has already resulted in faster serialization processing and improved packaging floor productivity. It has also enhanced real-time visibility across export supply chains. These capabilities are becoming critical as pharmaceutical manufacturers respond to evolving regulatory mandates and increasing supply chain complexity.

“As supply chains become more complex, limited data access in legacy systems is becoming a growing challenge. While technology has advanced, many systems have not kept pace. Today, pharmaceutical companies need solutions that provide greater control over their data and processes. AltiusHub has enabled our teams to manage serialization and traceability workflows with greater transparency, flexibility, and independence.” - Dr Bhaskar Reddy, Director, Hetero Group

“We need systems that give our teams real-time visibility, faster issue resolution, and greater control over compliance workflows. AltiusHub has helped us simplify these operations while improving efficiency across the packaging and dispatch process.” - Mr Sridhar Reddy, Operations Head, Annora Pharma 

“For a long time, pharma companies have had to accept that traceability implementations are slow, resource-intensive, and heavily dependent on vendors. AltiusHub’s go-live at Annora Pharma shows that this model is changing. An AI-native solution like AltiusHub delivers speed, scalability, and control while meeting the strict regulatory standards the industry requires.” - Siddharth Reddy, Managing Director, AltiusHub

Within two years of inception, AltiusHub has enabled serialization and compliance operations across more than 50 regulated markets. These include the United States under DSCSA, the European Union under FMD, Saudi Arabia under SFDA, the UAE under Tatmeen, Russia under Chestny ZNAK, and other export destinations.

AltiusHub has also supported pharmaceutical traceability requirements for public health supply programs serving African markets under global healthcare initiatives.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026
Why Young Indians Are Facing Heart Problems: Causes, Symptoms, and PreventionAugust 01, 2026
The Future of Preventive Screening: AI-Driven Early Cancer Detection in IndiaJuly 31, 2026
The Impact of Climate Change on Allergic Respiratory Diseases in Indian Cities July 31, 2026
Electronic Medical Records: What They Are, Why They Matter, and How India Is Embracing ThemJuly 31, 2026
Heatwave Health Risks in India: Symptoms, Treatment, and Prevention StrategiesJuly 31, 2026
Rare Chest Wall Reconstruction at SRM Global Hospital Saves Critically Injured Road Accident VictimJuly 30, 2026
52-Year-Old Male with just 10% Heart Function successfully revived at Fortis Greater Noida via High-Risk Emergency AngioplastyJuly 30, 2026
Yashoda Hospitals Hitec City Achieves Landmark Milestone of 400+ Renal Transplants in less than 4 YearsJuly 30, 2026